پایان نامه دانش و نگرش دانشجویان در زمینه عفونت با ویروس پاپیلومای انسانی و سرطان دهانه رحم و درک از رفتارهای خطرزا دراین زمینه

فهرست مندرجات

چکیده. ل

فصل اول: مقدمه و اهداف.. 1

1-1-مقدمه. 2

2-1-بیان مسئله. 4

3-1-اهداف پژوهش…. 8

1-3-1-هدف اصلی طرح.. 8

2-3-1-اهداف جزئی طرح.. 8

3-3-1-اهداف كاربردی طرح.. 9

4-1-فرضیات پژوهش…. 10

5-1-تعاریف نظری و عملکردی.. 11

1-5-1-نگرش…. 11

2-5-1-دانش…. 12

3-5-1-درک… 13

فصل دوم: مروری بر پژوهش های پیشین.. 15

1-2-معرفی HPV. 16

1-2-تاریخچه: 19

2-2-راه انتقال HPV. 20

3-2-عوامل هورمونی و تولیدمثلی.. 24

4-2-سیستم ایمنی.. 27

5-2-ویروس شناسی.. 29

6-2-پیشگیری.. 29

7-2-تشخیص…. 32

1-7-2-پاپ اسمیر. 32

2-7-2-تست های HPV. 33

3-7-2- کولپوسکوپی.. 33

4-7-2-گایدلاین های انجمن آمریکا برای تشخیص زودرس سرطان دهانه رحم: 36

جدول 1-2: میزان بقای پنج ساله سرطان دهانه رحم بر اساس گرید بیماری.. 37

5-7-2-پاپیلوماتوزیس تنفسی.. 38

6-7-2-به مخاطره انداختن سیستم ایمنی.. 38

فصل سوم: روش های تحقیق.. 61

1-3-متغیرها 62

1-1-3-متغیرهای مخدوش کننده. 62

2-1-3-متفیر های دمدگرافیک…. 62

2-3-نوع مطالعه. 62

1-2-3-جمعیت مطالعه. 62

3-3-ابزار پژوهش…. 62

4-3-مکان و زمان انجام مطالعه. 65

5-3-روش جمع آوری داده ها 65

6-3-ملاحظات اخلاقی: 65

7-3-روش تجزیه و تحلیل داده ها: 66

8-3-محدودیت ها 66

فصل چهارم: یافته ها. 68

فصل پنجم: بحث و نتیجه گیری.. 80

1-5-رفتارهای مرتبط با سلامت دانشجویان دختر. 81

2-5-دانش دانشجویان دختر راجع به رفتارهای خطر مرتبط با عفونت با ویروس پاپیلومای انسانی و سرطان دهانه رحم.. 82

3-5-درک دانشجویان دختر از رفتارهای خطر مرتبط با عفونت با ویروس پاپیلومای انسانی و سرطان دهانه رحم.. 85

4-5-نگرش دانشجویان دختر راجع به رفتارهای خطر مرتبط با عفونت با ویروس پاپیلومای انسانی و سرطان دهانه رحم.. 87

5-5-نتیجه گیری نهایی.. 88

6-5-پیشنهادات برای پژوهش های بعدی.. 89

7-5-کاربرد در پرستاری.. 89

منابع و مواخذ.. 91

فهرست جداول

جدول 1-4: توزیع فراوانی نسبی و مطلق اطلاعات زمینه ای دانشجویان دختر پرستاری و مامایی دانشکده پرستاری – مامایی رازی در سال 1393-1392. 68

جدول 2-4: توزیع فراوانی نسبی و مطلق “رفتارهای مرتبط با سلامت دانشجویان دختر پرستاری و مامایی دانشکده پرستاری- مامایی رازی در سال 1393-1392. 69

جدول 3-4: توزیع فراوانی نسبی و مطلق دانش دانشجویان دختر پرستاری ومامایی دانشکده پرستاری- مامایی رازی راجع به عفونت با ویروس پاپیلومای انسانی و سرطان دهانه رحم در سال 1393-1392. 70

جدول 4-4: توزیع فراوانی نسبی و مطلق درک دانشجویان دختر پرستاری و مامایی دانشکده پرستاری – مامایی رازی از رفتارهای خطر مرتبط با عفونت با ویروس پاپیلومای انسانی و سرطان دهانه رحم در سال 1393-1392. 71

جدول 5-4: ارتباط اطلاعات دموگرافیک دانشجویان دختر پرستاری و مامایی دانشکده پرستاری – مامایی رازی با دانش، درک و نگرش آتها راجع به عفونت با ویروس پاپیلومای انسانی و سرطان دهانه رحم و رفتارهای خطر در این زمینه در سال 1393-1392. 74

جدول 6-4: ارتباط تجارب شخصی دانشجویان دختر پرستاری و مامایی دانشکده پرستاری- مامایی رازی با دانش، درک ونگرش آنها راجع به عفونت با ویروس پاپیلومای انسانی و سرطان دهانه رحم و رفتارهای خطر در این زمینه در سال 1393-1392. 75

جدول 7-4. ارتباط دانش، درک و نگرش دانشجویان دختر پرستاری و مامایی دانشکده پرستاری – مامایی رازی راجع به عفونت با ویروس پاپیلومای انسانی و سرطان دهانه رحم در سال 1393-1392. 77

فهرست ضمائم و پیوست ها

پیوست 1 : پرسشنامه. 111

1. Obradovic M MAKM. Cost- effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia. European Journal of Public Health. 2010;20:415-21.
2. Jack Cuzick1, *,Christine Clavel2, Karl-Ulrich Petry3, Chris J.L.M. Meijer4, Heike Hoyer5, Samuel Ratnam6, Anne Szarewski1, Philippe Birembaut2, Shalini Kulasingam7, Peter Sasieni1 and Thomas Iftner8. South Carolina Community Assessment Network. South Carolina Department of Health and Environmental Contro URL: http://scangis.dhec.sc.gov/scan; 2011 [
3. Eva Yacobi BA, * Colleen Tennant, MSPH,† Jeanne Ferrante, M.D.,† Naazneen Pal, B.A.,†, and Richard Roetzheim MD, MSPH†,‡,2. University Students’ Knowledge and Awareness of HPV1. Preventive Medicine 1999;28:535-14.
4. AparecidaCiriloC SZ. Level of behavior and knowledge SociedadeBrasileira de Medicina Tropica. 2010;143:362-6.
5. A SDB. A survey of female nursing students’ knowledge, health beliefs, perceptions of risk and risk behaviors regarding human papillomavirus and cervical cancer. J American Academy of Nurse Practitioners. 2005;18:62-9.
6. Winer R LS, Hughesh P, Adam D, Kiviat N & Koutsky L Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students.. American Journal of Epidemiology. 2002;157:218-26.
7. Society AC. 2015.
8. Moreira ED OB, Ferraz FM,CostaS,Costafilho JO&KaricG. Knowledge and attitudes about human papillomavirus, pap smears and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer. 2006;16:599-603.
9. Nganwai P TP, Inpa C, Sangpetngam B, Mekjarasnapa M, Apiracarn M & Chumworathay B. Knowledge, Attitudes and practices vis-à-vis cervical cancer among registered nurses at the faculty of medicine khonkaen university, Thailand. Asian pacific J cancer prev,. 2007;9:15-8.
10. E UMD. Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania. African Health Sciences. 2011;11(1):48-57.
11. Richardson H KGTP. The natural history of type- specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev. 2003;12:485-90.
12. Ghojazadeh F, SalehP, Naghavi-BehzadM&GhodratnezhadAzarN Knowledge and attitude of Iranian university students toward human papillomavirus.. Asian Pacific J Cancer Prev13, 6115-6119. 2012;13:6115-9.
13. KaubiO MP. Human papillomavirus and cervical cancer prevention: knowledge and attitudes among women in Lusaka Urban. Niger J Clin Pract. 2011;12:341-2.
14. CrocettiE M, BeatrizVisioliC&ZappaM. Risk of invasive cervical cancer and cervical intraepithelial neoplasia grade III in central Italy by area of birth Med Screen. 2010;17:87-90.
15. Watson-Jones D BKBJ. High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects. Sex Transm Infect. 2012;89:358-65.
16. Kobetz E DMMJ. One size does not fit all: differences in HPV knowlege between Haitian and African American women. Cancer Epidemiol Biomarkers Prev. 2010;19:366-70.
17. Ross AO. Personality: The Scientific Study of Complex Human Behavior1987.
18. Urban dictionary. 1986. Urban dictionary.
19. Callahan RE, Fleenor, C. P. & Knudson, H. R. Understanding organizational behavior: A managerial viewpoint, CE Merrill Publishing Company.. 1986.

20. Callahan RE, Fleenor CP, Knudson HR. Understanding organizational behavior: A managerial viewpoint: CE Merrill Publishing Company; 1986.
21. Razban F, Iranmanesh, S. & Rafiei, H. Nurses attitudes toward palliative care in south -east Iran. International journal of palliative nursing. 2011;19:403-10.
22. FAZIO RH. Attitudes as object-evaluation associations: Determinants, consequences, and correlates of attitude accessibility. 1995;214.
23. EAGLY AH, & CHAIKEN, S The psychology of attitudes. Harcourt Brace Jovanovich College Publishers. 1993.
24. Visser P, Bizer, G. &, K., J. Exploring the latent structure of strength -related attitude attributes. Advance in experimental social psychology. 2006;38(67).
25. HOCKENBURY D. Discovering psychology.. New York. 2007..
26. Davenport T, & Grover, V. Knowledge Management. Journal of Management Information Systems. 2001;18(1):3-4.
27. K P. The logic of scientific discovery. edition n, editor. New York: NY: rout ledge classic; 2002.
28. Cohen WL. Absorptive Capacity: A New Perspective on Learning and Innovation. Administrative Science Quarterly. 1990;35:128-52.
29. Nonaka T. the knowledge -cratting company: how japanease companies create the dynamics of innovation,. oxford university press. 1995.

38. Cancer AJCo. 2010.
39. Hunter MI MBaTK. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. Am J Obstet Gynecol. 2008;199(1):3-9.
40. Schiffman M CPC. “Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med. (August 2003);127(8):930-4.
41. Alam S CM, Chen HS, Meyers C. “Cigarette Smoke Carcinogen Benzo[a]pyrene Enhances Human Papillomavirus Synthesis. “Cigarette Smoke Carcinogen Benzo[a]pyrene Enhances Human Papillomavirus Synthesis. 2007;82(2):1053-8.
42. Stanley MAW, David M; Sterling, Jane C; Goon, Peter KC HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues. BMC Cancer. 2012;12(1):398.
43. Lechner M FG, Fenton T, Feber A, Palmer G, Jay A, Pillay N, Forster M, Cronin MT, Lipson D, Miller VA, Brennan TA, Henderson S, Vaz F, O’Flynn P, Kalavrezos N, Yelensky R, Beck S, Stephens PJ, Boshoff C; Boshoff, G. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors. Genome Medicine. 2013;5(5):49.
44. Muñoz NB, F. X.; De Sanjosé, S; Herrero, R; Castellsagué, X; Shah, K. V.; Snijders, P. J.; Meijer, C. J. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group “NEJM”, The New England Journal of Medicine 2003;348(6):518-27.
45. DM P. Cancers attributable to infection in the UK in 2010 Br. J Cancer 2011. 2011;105(S2):49-56.
46. Sinal SH WC. Human papillomavirus infections of the genital and respiratory tracts in young children. Seminars in pediatric infectious diseases. 2005;16(4):306-16.
47. SK T. “Genital oncogenic human papillomavirus infection: a short review on the mode of transmission. Annals of the Academy of Medicine, Singapore. 1995;24(4):598-601.
48. Burchell AN RH, Mahmud SM, Trottier H, Tellier PP, Hanley J, Coutlée F, Franco EL Modeling the Sexual Transmissibility of Human Papillomavirus Infection using Stochastic Computer Simulation and Empirical Data from a Cohort Study of Young Women in Montreal, Canada. American Journal of Epidemiology. 2006;163(6):534-43.
49. Winer RL HJ, Feng Q, Xi LF, Cherne S, O’Reilly S, Kiviat NB, Koutsky LA “Detection of genital HPV in fingertip samples of newly sexually active female university students. Cancer Epidemiology Biomarkers & Prevention 2010;19(7):1682-5.
50. Hans Krueger; Gavin Stuart; Richard Gallagher; Dan Williams JK. HPV and Other Infectious Agents in Cancer: Opportunities for Prevention and Public Health: Opportunities for Prevention and Public Health. Oxford University Press. 12 April 2010:34.
51. Bodaghi S WL, Roby G, Ryder C, Steinberg SM, Zheng ZM. “Could human papillomaviruses be spread through blood? J Clin Microbiol. 2005;43(11):5428.
52. “Human Papillomavirus: Confronting the Epidemic—A Urologist’s Perspective”. nihgov.
53. Parfenov M. Characterization of HPV and host genome interactions in primary head and neck cancers. Proceedings of the National Academy of Sciences 111:15544-9.
54. RA W. “Human Papillomavirus: Confronting the Epidemic—A Urologist’s Perspective. Reviews in Urology. 2005;7(3):135-44.
55. DM P. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118(12):2030-44.
56. KA A. Epidemiology and natural history of Human papillomavirus infections in the female genital trac. Infectious Diseases in Obstetrics and Gynecology. 2006:1-5.
57. HealWithFood.org 2010-2015 [
58. ML G. Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol. 2006;24(36):5623-5.
59. Chin-Hong PV VE, Cranston RD, Browne L, Buchbinder S, Colfax G, Da Costa M, Darragh T, Benet DJ, Judson F, Koblin B, Mayer KH, Palefsky JM Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst. 2005;97(12):896-905.
60. Goldie SJ KK, Weinstein MC, Freedberg KA, Palefsky JM Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus negative homosexual and bisexual men. Am J Med. June 2000;108(8):634-41.
61. Anttila A PE, Sallmen M,et al. cancer incidence among finish workers exposed to halogenated hydrocarbons. J occup Environ Med. 1995;37:797-806.
62. Centers for Disease Control and Prevention. DES update.

 http://www.cdc.gov/DES 2004 [

64. Lountzis NI RO. Images in clinical medicine. Digital verrucae. N Engl J Med. 2008;359(2):177.
65. Giusti RM IK, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med. 1995;122:778-88.
66. RJ S. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance of male and female offspring. Am J Obstet Gynecol. 1982;142:905-21.
67. Wu R SS, Steinberg BM. Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium. Mol Med. 2003;9(3-4):77-84.
68. Society AC. 2014.
69. Goldstein MA GA, Del Carmen MG, Wilbur DC; Goodman; Del Carmen, MG; Wilbur Case records of the Massachusetts General Hospital. Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear. N Engl J Med. Goldstein MA, Goodman A, Del Carmen MG, Wilbur DC; Goodman; Del Carmen, MG; Wilbur 360(13):1337-44.
70. Bzhalava DG, P; Franceschi, S; Dillner, J; Clifford, G A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology. 2013;445(1-2):224-31.
71. Greer CE WC, Ladner MB, Beutner K, Coyne MY, Liang H, Langenberg A, Yen TS, Ralston R ”Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol. 1995;33(8):2058-63.
72. Mayo Clinic.com, Common warts, http://www.mayoclinic.com/print/common-warts/DS00370/DSECTION=all&METHOD=print [
73. Burchell AN WR, de Sanjosé S, Franco EL. Epidemiology and transmission dynamics of genital HPV infection. Vaccine. Aug 2006; 24 Suppl (3):52-61.
74. Egendorf L. Sexually Transmitted Diseases. New York: Greenhaven Press. 2007((At Issue Series).
75. Schiller JT DP, Kines RC. “Current understanding of the mechanism of HPV infection. Gynecologic Oncology. 2010;118(1 Suppl):12.
76. Muñoz N CX, de González AB, Gissmann L; Castellsagué; De González HPV in the etiology of human cancer. Vaccine 2006;24(3):1-10.
77. Humman Papillomavirus at e medicine.
78. Gavillon N VH, Derniaux E, Terrosi P, Graesslin O, Quereux C. Papillomavirus humain (HPV): comment ai-je attrapé ça? Gynécologie Obstétrique & Fertilité. 2010;38(3):199-204.
79. pape Wp. Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec. 2009;84(15):118-31.
80. sin hang lee jsv, veronicas.vigliotti and william jones. cancers. 2014;6:2072-99.
81. Markowitz LE DE, Saraiya M, Lawson HW, Chesson H, Unger ER. “Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)”. MMWR Recomm Rep. 2007;56 (RR–2):1-24.
82. Harper DDM. “An Interview with Dr. Diane M. Harper, HPV Expert. In: Yerman MG, editor. Huffington Post2010.
83. “FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV”. Retrieved 28 February 2015. ed10 December 2014.
84. CDC. “CDC — Condom Effectiveness — Male Latex Condoms and Sexually Transmitted Diseases”. Centers for Disease Control and Prevention (CDC). October 22, 2009. Retrieved 23 October 2009..
85. Bleeker MC BJ, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Starink TM, Snijders PJ, Meijer CJ. “HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions. Br J Cancer. 2005;92(8):1388-92.
86. Howett MK KJ. Microbicides for prevention of transmission of sexually transmitted diseases. Current Pharmaceutical Design. November 2005;11(29):3731-46.
87. National Cancer Intelligence Network. 2011.
88. Pathology ASfC. American Society for Clinical Pathology, “Five Things Physicians and Patients Should Question”, Choosing Wisely: an initiative of the ABIM Foundationretrieved 1 August 2013.
89. NCI. 2013.
90. SahebJamee M BM, Ghaffari SR, AtarbashiMoghadam F, Keyhani A. “Human papillomavirus in saliva of patients with oral squamous cell carcinoma”. Medicina oral, patologia oral y cirugia bucal. 2009;14(10):525-8.
91. Aguilar LV L-PE, Vaccarella S, Cruz A, Hernández P, Smith JS, Muñoz N, Kornegay JR, Hernández-Avila M, Franceschi S “Human papillomavirus in men: Comparison of different genital sites”. Sexually Transmitted Infections. 2006;82(1):31-3.
92. Giuliano AR NC, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, Markowitz LE, Smith D, Harris RB The Optimal Anatomic Sites for Sampling Heterosexual Men for Human Papillomavirus (HPV) Detection: The HPV Detection in Men Study”. The Journal of Infectious Diseases 2007;196(8):1146-52.
93. Antonsson A FO, Ekberg H, Sterner G, Hansson BG. “The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol. 2000;74(24):116336-11641.
94. De Koning MN QK, Bruggink SC, Gussekloo J, Bouwes Bavinck JN, Feltkamp MC, Quint WG, Eekhof JA “High prevalence of cutaneous warts in elementary school. 2014.
95. “Human papillomavirus vaccines. WHO position paper”. Wkly Epidemiol Rec. April 2009.;84(15).
96. Schiffman M CPC. The promise of global cervical-cancer prevention”. N Engl J Med. 2005;353(20):2101-4.
97. Lu B HM, Lee JH, Wu Y, Stockwell HG, Nielson CM, Abrahamsen M, Papenfuss M, Harris RB, Giuliano AR. “Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men. Cancer Epidemiol Biomarkers Prev. (February 2010);19(2):511-6.
98. J C. Public health. High hopes and dilemmas for a cervical cancer vaccine. Science. 2005;308(5722):618-321.
99. Noel J LL, Fayt I, Verhest A, Dargent J. of human papilloma virus infection but lack of Epstein-Barr virus in lymphoepithelioma-like carcinoma of uterine cervix: report of two cases and review of the literature”. Hum Pathol. 2001;32(1):135-8.
100. Bolt J VQ, Kim WJ, McWhorter AJ, Thomson J, Hagensee ME, Friedlander P, Brown KD, Gilbert J The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms. Oral Oncol. 2005;41(10):1013-20.
101. Kuo HK FK. Human papillomavirus and cardiovascular disease among u.s. Women in the national health and nutrition examination survey, 2003 to 2006. Journal of the American College of Cardiology 2011-11-01;58(19):2001-6.

104.

“Human Papillomavirus Epidemiology and Prevention of Vaccine-Preventable Diseases”

CDCgov. Retrieved 30 January 2014.

.

105. statistics ofN. Cancer Registration Statistics. 2013 ed. England2011.
106. Coleman MP BP, Damiecki P, Grosclaude P, Honjo S, Jones J, et al.. Cancer survival trends in England and Wales, 1971-1995: deprivation and NHS region. London: Stationery Office.; 1999.
107. “HPV — the Shy Virus”. 2008.
108. Moore CE WB, McClatchey KD, Koopmann CF, Thomas GR, Bradford CR, Carey TE “High-risk human papillomavirus types and squamous cell carcinoma in patients with respiratory papillomas”.. Otolaryngol Head Neck Surg 1999;120(5):698-705.
109. NCCC. 2008.
110. CDHA. 2001.
111. Greenblatt RJ. Human papillomaviruses: Diseases, diagnosis, and a possible vaccine. Clinical Microbiology Newsletter 2005;27(18):139-45.
112. Chaturvedi AMLG. “Human Papillomavirus and Head and Neck Cancer”. In Andrew F. Olshan. Epidemiology, pathogenesis, and prevention of head and neck cancer (March 4, 2010;1.
113. D’Souza G KA, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. ”Case-control study of Human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944-56.
114. Network. NCI. 2011.
115. Nilgün Güdücü GG, Herman İşçi, Alin Başgül Yiğiter, İlkkan Dünder. Awareness of human papilloma virus, cervical cancer and HPV vaccine in healthcare

workers and students of medical and nursing schools. Journal of Clinical and Experimental Investigations. 2012;3(3):318-25.

122. R NaikP NNS. Awareness of cervical cancer and effectiveness of educational intervention programme among nursing students in a rural area of Andhra Pradesh. Healthline. 2012;3(2):41-5.
123. ChoiS.Y. Development of an educational program to prevent cervical cancer among immigrant in Korea. Asian Pac J Cancer Prev. 2013;14(9):5345-9.
124. A.MontgomeryK&BlochJ.R. HPV and cervical cancer knowledge in high risk older women. American Journal of Health Studies. 2009;19(1):28-35.
125. A.RegierD He. Exploring colposcopist s attitudes towards use of HPV testing as a primary screening tool for cervical cancer in British Columbia. J Obstet Gynnaecol Can. 2013;35(7):657-63
126. R Caron EK, R McGrath. Human Papillomavirus (HPV) Vaccine: Attitudes, Behaviors, and Beliefs of At-Risk Women. The Internet Journal of Health. 2008;9(2).
127. Kimberly M. Kelly P, MS,Amy K. Ferketich, PhD,Mack T. Ruffin IV, MD, MPH,,Cathy Tatum, MS, and Electra D. Paskett, PhD. Perceived Risk of Cervical Cancer in Appalachian Women. Am j health behave2012. 2012;36(6):849-59.
128. C.MupepisS SRBJ. knowledge, attitudes, and demographic factors influencing cervical cancer screening behaviors of Zimbabwean women. Journal of woman’s health. 2010;20(number6.2012).
129. JohnJ. knowlege, attitude, practice and perceived barriers towards screening for premalignant lesions among women aged 18years and above, in Songea Urban, Ruvuma. 2011.
130. HongY Z, LiX,LinD&LiuY. HPV and cervical cancer related knowledge, awareness and testing behaviors in a community sample of female sex workers in Chine. BMC public health2013 2013;13(696).
131. GhotbiN&AnaiA. Assessment of the knowledge and attitude of female students toward cervical cancer prevention at an international university in Japan. Asian pacific J cancer prev,. 2012;13:897-900.
132. G.OscarssonM QT. Attitude to cervical cancer screening and sexual behavior among HPV vaccinated young women –A qualitative pilot study. Health2013. 2013;5(7):13-8.
133. H.SaitK. Knowledge, attitudes and practices regarding cervical cancer screening among physicians in the western region of Saudi Arabic. Saudi Med J 2011. 2011;32(11):1155-60.
134. WongL.P. Knowledge and attitudes about HPV infection, HPV vaccination, and cervical cancer among rural Southeast Asian women. IntJBehavMed. 2010.
135. TchoungaB.K Je. Cervical cancer prevention in reproductive health services: Knowledge, attitudes and practices of midwives in Cote d lvoire, Wwst African. BMC Health Services Research2014. 2014;14(165).
136. OwoeyeI.O.G&Ibrahim.I.A. Knowledge and attitude towards cervical cancer screening among female students and staff in a tertiary institution in the Niger Delta. Int J Med Biomed. 2013;2(1):48-56.
137. HodgeFS. American Indian male college student’s perception and knowledge of Human papillomavirus (HPV). J vaccines vaccine. 2014;5(2).
138. Labani SAaS. factors Associated with Attitudes of Rural Women Toward Cervical Cancer Screening. Indian J Community Med. 2013;38(4):246-8.
139. Kangh.y&KimJ.S. Knowledge, attitudes of human papillomavirus vaccine, and intention to obtain vaccine among Korean female under graduated students. Women and Health. 2011;51:759-76.
140. Hwaid AH. knowledge and awareness of papillomavirus and cervical cancer among college students and health care workers in Diyala,Iraq. journal of public health research. 2013;1(18):221-5.
141. Lechner M FG, Fenton T, Feber A, Palmer G, Jay A, Pillay N, Forster M, Cronin MT, Lipson D, Miller VA, Brennan TA, Henderson S, Vaz F, O’Flynn P, Kalavrezos N, Yelensky R, Beck S, Stephens PJ, Boshoff C; Boshoff, G. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors”. Genome Medicine (2013);5(5):49.
142. NnoduO E, etal. Knowledge and attitudes towards cervical cancer and Human papillomavirus: A Nigerian pilot study. African Journal of Reproductive Health. 2010;14(1):95-108.
143. Statistics OfN. Cancer Survival in England: Patients Diagnosed 2007-2011 and Followed up to 2012.
144. Yingfei Ma aRM, b Ulas Karaoz,c Carlos W. Nossa,d Liying Yang,a Shibu Yooseph,e Patrick S. Yachimski,f Eoin L. Brodie,cYilmazelG&Buyukhayaci DumanN Knowledge, attitudes and beliefs about cervical cancer and Human papillomavirus vaccination with related factors in Turkish university students. Asian Pac J cancer prev,. 2014;15(8):3699-704.
145. YoshinoY O, KawashimaM,WadaK,ShimizuM,SakaguchiH,OkadaJ&AizawaY. The knowledge of cervical cancer and screening among nurses at a university – affiliated hospital in Japan. -14Kitasato Med J. 2011;6:6.
146. M.KellyK KF, T.RuffinM, TatumC&D.PaskettE. Perceived risk of cervical cancer in Appalachia women. Am j health behave2012. 2013;36(6):849-59.
147. Catherine McCarey1*† DP, Pierre Marie Tebeu2, Michel Boulvain3, Anderson Sama Doh4 and Patrick Petignat5. Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Women’s Health. 2011.

144. H RashawanH NA. Knowledge, attitude and practice of Malaysian medical and pharmacy students towards Human Papillomavirus vaccination. Asian pacific J cancer prev,. 2012;13:2279-83.
145. DumanN YB. Knowledge, attitudes and beliefs about cervical cancer and Human papillomavirus vaccination with related factors in Turkish university students. Asian Pac J cancer prev. 2014;15(8):3699-704.
146. Maria Labadiari1 CM, Evagelia Harisi3, Dimitra Argiropoulou4, Ioulia Stiga5, Stiliani Mouchaki6, Christos Katsoulas7, Georgia Fouka8. Socioeconomic factors, prior carrying out of Pap smear and knowing of the HPV-vaccine among nursing students. Health Science Journal. 2010:280-9.